Mirochnick M, Meyer J, Cole J, Herren T, Zuckerman B
Department of Pediatrics, Boston City Hospital, MA 02118.
Pediatrics. 1991 Sep;88(3):481-5.
Twenty newborns, 12 with prenatal exposure to cocaine and an unexposed control group of 8, were studied to determine concentrations of circulating catecholamines and their relationship to newborn behavior. Birth weight of the cocaine-exposed neonates was significantly lower than that of the control group. Gestational age, length, and head circumference of the cocaine-exposed neonates were also lower, although the differences did not reach statistical significance. Between 24 and 48 hours of age, circulating concentrations of norepinephrine, dopamine, and the catecholamine precursor dihydroxyphenylalanine were measured and behavior was assessed using the Neonatal Behavioral Assessment Scale. Mean dihydroxyphenylalanine concentrations were increased in the cocaine-exposed newborns (10.3 ng/mL vs 5.9 ng/mL, P = .055), while there was no difference between the groups in mean norepinephrine or dopamine concentrations. There was a significant negative correlation between norepinephrine concentration and orientation cluster score for the cocaine-exposed newborns (r2 = .6979, P = .005). norepinephrine concentration did not correlate with the score for any other behavioral cluster, nor did dopamine or dihydroxyphenylalanine concentration correlate with the score for any cluster. These preliminary data from a pilot study suggest that catecholamine activity is increased in cocaine-exposed newborns and may play a role in neurobehavioral disturbances associated with prenatal exposure to this drug.
对20名新生儿进行了研究,其中12名在产前接触过可卡因,另有8名未接触过可卡因的对照组,以确定循环儿茶酚胺的浓度及其与新生儿行为的关系。接触可卡因的新生儿出生体重显著低于对照组。接触可卡因的新生儿的胎龄、身长和头围也较低,尽管差异未达到统计学意义。在出生后24至48小时之间,测量了去甲肾上腺素、多巴胺和儿茶酚胺前体二羟基苯丙氨酸的循环浓度,并使用新生儿行为评估量表对行为进行了评估。接触可卡因的新生儿中二羟基苯丙氨酸的平均浓度升高(10.3 ng/mL对5.9 ng/mL,P = 0.055),而两组之间去甲肾上腺素或多巴胺的平均浓度没有差异。对于接触可卡因的新生儿,去甲肾上腺素浓度与定向集群得分之间存在显著负相关(r2 = 0.6979,P = 0.005)。去甲肾上腺素浓度与任何其他行为集群的得分均无相关性,多巴胺或二羟基苯丙氨酸浓度与任何集群的得分也无相关性。这项初步研究的这些数据表明,接触可卡因的新生儿儿茶酚胺活性增加,可能在与产前接触该药物相关的神经行为障碍中起作用。